[1] Fang C, Anupindi SA, Back SJ, et al. Contrast-enhanced ultrasound of benign and malignant liver lesions in children. Pediatr Radiol,2021,51(12):2181-2197. [2] Shahryari M, Tzschatzsch H, Guo J, et al. Tomoelastography distinguishes noninvasively between benign and malignant liver lesions. Cancer Res,2019,79(22):5704-5710. [3] Shen H, Lyu G, Lin H, et al. Development of an ultrasound Prediction model to discriminate between malignant and benign liver lesions. Ultrasound Med Biol,2020, 46(4):952-958. [4] Li Y, Zhang Y, Fang Q, et al. Radiomics analysis of FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging,2021,48(8):2599-2614. [5] Shao L, Wang X, Yu Y, et al. Comparative analysis of the efficacy and accuracy of magnetic resonance imaging (MRI) and contrast-enhanced CT for residual and new lesions after transcatheter arterial chemoembolization (TACE) in patients with primary liver cancer. Transl Cancer Res,2021,10(8):3739-3747. [6] Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol,2019, 70(6):1133-1144. [7] Kuipers H, Hoogwater FJ, Holtman GA, et al. Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysis. Acta Radiol,2021,62(8):987-996. [8] Umemura Y, Wang D, Peck KK, et al. DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy. J Neurooncol,2020, 146(2):339-346. [9] Wen L, Xin B, Wu P, et al. An efficient combination immunotherapy for primary liver cancer by harmonized activation of innate and adaptive immunity in mice. Hepatology, 2019, 69(6):2518-2532. [10] 赵升, 赵雷, 张锐,等.11C-乙酸盐与18F-FDG PET/CT联合显像在原发性肝癌诊断中的应用. 中华核医学与分子影像杂志, 2018,38(9):623-624. [11] Di Tommaso L, Spadaccini M, Donadon M, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol,2019,25(40):6041-6052. [12] Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.J Hepatol,2019, 70(6):1133-1144. [13] Hwang JA, Min JH, Kang TW, et al. Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT. Eur Radiol,2021, 31(10):7760-7770. [14] Rimola J, Forner A, Sapena V, et al. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Eur Radiol,2020,30(1):186-194. [15] Zhu Y, Wang S, Xi X, et al. Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. Theranostics, 2021,11(1):181-193. [16] 陈青华, 王新艳, 张冰,等. 动态增强磁共振成像定量参数预测和评估鼻腔鼻窦恶性肿瘤化疗效果的初步探讨. 中华医学杂志, 2019, 99(23):1773-1777. [17] Song Q, Guo Y, Yao X, et al. Comparative study of evaluating the microcirculatory function status of primary small HCC between the CE (DCE-MRI) and non-CE (IVIM-DWI) MR perfusion imaging. Abdom Radiol (NY),2021,46(6):2575-2583. [18] Berks M, Little RA, Watson Y, et al. A model selection framework to quantify microvascular liver function in gadoxetate-enhanced MRI: Application to healthy liver, diseased tissue, and hepatocellular carcinoma. Magn Reson Med,2021,86(4):1829-1844. [19] Zhou Q, Tian W, Jiang Z, et al. A positive feedback loop of AKR1C3-mediated activation of NF-κB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma. Cancer Res,2021,81(5):1361-1374. [20] Fortunel NO, Chadli L, Coutier J, et al. KLF4 inhibition promotes the expansion of keratinocyte precursors from adult human skin and of embryonic-stem-cell-derived keratinocytes. Nat Biomed Eng,2019, 3(12):985-997. |